Evaluating lactate metabolism for prognostic assessment and therapy response prediction in gastric cancer with emphasis on the oncogenic role of SLC5A12
The LRGS is a dependable and efficient prognostic tool for assessing the survival outcomes in individuals with gastric cancer, as well as a predictor of patient response to adjuvant chemotherapy and immunotherapy.
Authors
- Lin Yao (ORCID: https://orcid.org/0000-0002-5948-2249)
- Chen-Yi Lin
- Ying Zheng (ORCID: https://orcid.org/0000-0002-1906-9660)
- Liangjie Chi (ORCID: https://orcid.org/0000-0002-2231-038X)
- Qingshui Wang (ORCID: https://orcid.org/0000-0002-1714-1737)
- Feng Li (ORCID: https://orcid.org/0009-0006-3814-4925)
- Jia Lin (ORCID: https://orcid.org/0000-0001-6497-4267)
- Yining Xu (ORCID: https://orcid.org/0009-0000-5559-2347)
- Jianjian Ye
- Chao Xu
- Yun Chen (ORCID: https://orcid.org/0009-0001-3783-2199)
Institutions
- Fujian Normal University (CN)
- Fujian University of Traditional Chinese Medicine (CN)
- Fujian Medical University (CN)
- Fuzhou Second Hospital (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
- Fujian Provincial Hospital (CN)
- Putian University (CN)
Publication Details
- Journal
- Biochimica et Biophysica Acta (BBA) - General Subjects
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1016/j.bbagen.2024.130739
- Citations
- 2
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.47